Memantin Hcs (Memantine Hydrochloride)

Memantin Hcs is an NMDA receptor antagonist indicated for the management of Alzheimer’s disease, where it provides symptomatic benefit.

• Alzheimer’s disease (moderate to severe): helps maintain cognitive function and daily activities in patients with moderate to severe disease.

• Memantine acts as a non‑competitive antagonist at the N‑methyl‑D‑aspartate (NMDA) receptor. By binding to the receptor-associated ion channel with moderate affinity, it blocks excessive calcium influx caused by overstimulation, thereby reducing excitotoxic neuronal injury while preserving normal synaptic transmission essential for learning and memory.

Memantin Hcs may be associated with a range of adverse reactions.

Common Side Effects

• Dizziness: mild to moderate episodes of light‑headedness.
• Headache: transient, often resolves without intervention.
• Constipation: reduced bowel movements, may require dietary adjustment.
• Fatigue: feeling of tiredness or reduced energy.
• Hypertension: occasional increase in blood pressure.
• Confusion: transient mental clouding, especially at treatment initiation.

Serious or Rare Side Effects

• Seizures: rare occurrence, requires immediate medical attention.
• Cardiac arrhythmia: irregular heart rhythms reported in isolated cases.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Stevens‑Johnson syndrome: severe skin reaction, discontinue use promptly.
• Suicidal thoughts: emergent mood changes warrant urgent evaluation.
• Severe allergic reaction: rash, swelling, or anaphylaxis.

When prescribing Memantin Hcs, clinicians should consider several safety aspects.

• Renal impairment: adjust dose or monitor plasma levels in patients with reduced kidney function.
• Hepatic impairment: use with caution and monitor liver function tests.
• History of seizures: evaluate risk and monitor closely.
• Concomitant NMDA antagonists: avoid combined use to prevent additive neuro‑inhibition.
• Pregnancy: safety not established; weigh potential benefits against unknown risks.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Memantin Hcs can interact with other medicines, affecting its safety and efficacy.

Major Interactions (Avoid)

• Amantadine: additive NMDA antagonism may increase neuro‑psychiatric effects.
• Ketamine: combined NMDA blockade can lead to excessive sedation.
• Cimetidine: may raise memantine plasma concentrations.
• Quinidine: can reduce renal clearance of memantine.
• Other NMDA antagonists: heightened risk of CNS depression.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: may blunt cognitive benefits.
• Antipsychotics: monitor for increased confusion.
• SSRIs: watch for serotonin syndrome signs.
• Antihypertensives: possible additive blood pressure effects.
• NSAIDs: monitor renal function when used together.